Cell Press

Cell Press
Name	Cell Press
Founded	1974
Founder	Benjamin Lewin
Country	United States
Headquarters	Boston, Massachusetts
Publications	Scientific journals, magazines
Topics	Life sciences, physical sciences, medicine
Parent	Elsevier

Cell Press

Cell Press is an academic publisher specializing in life sciences and physical sciences journals, magazines, and digital media. Founded in 1974, it grew from a single flagship journal into a multidisciplinary portfolio covering molecular biology, neuroscience, immunology, oncology, and chemistry. The imprint operates as part of a multinational publishing group and interacts with major research institutions, funding agencies, and scholarly societies.

History

Cell Press was established in 1974 by Benjamin Lewin with the launch of the flagship journal Cell, positioning itself in the competitive landscape alongside Nature and Science. During the 1980s and 1990s the publisher expanded by launching specialty titles such as Neuron and Immunity, attracting editorial leadership drawn from institutions like the Massachusetts Institute of Technology and Harvard Medical School. In 1999 the imprint became part of the Elsevier portfolio, linking it to corporate units such as Elsevier and its parent groups, bringing it into broader debates involving bodies like the Wellcome Trust and the National Institutes of Health. Throughout the 2000s and 2010s the publisher adapted to digital transformation trends led by platforms used by organizations including PubMed Central and initiatives associated with the Open Access movement, while engaging with stakeholders such as the European Research Council and the Howard Hughes Medical Institute.

Publications and Journals

The publisher’s portfolio includes flagship and high-impact titles spanning molecular and cellular biology, neuroscience, immunology, and clinical research. Core journals include Cell, Cell Reports, Neuron, Immunity, Cancer Cell, Cell Stem Cell, and Cell Metabolism. The list extends to specialized outlets addressing structural biology, computational biology, and chemical biology that interact with scholarship from institutions such as Cold Spring Harbor Laboratory, Salk Institute, Broad Institute, and Francis Crick Institute. The publisher also produces magazine-style offerings that cover science policy and public engagement comparable to pieces found in outlets associated with The Lancet and Nature Communications.

Business Model and Ownership

Operating as an imprint within a large commercial publisher, the organization’s revenue model historically combined subscription access, site licensing with universities like University of California and University of Oxford, and article processing charges tied to open-access options. Corporate ownership by Elsevier situates it within a portfolio alongside brands such as The Lancet and connects it with business practices debated by consortia like the Coalition S (cOAlition S). Negotiations over big-deal contracts have involved consortia and national negotiators from entities including Germany’s Projekt DEAL, United Kingdom’s research councils, and universities such as Stanford University.

Editorial Policies and Peer Review

Editorial oversight is exercised through in-house editors and academic editorial boards recruited from leading universities and research institutes like University of Cambridge, Johns Hopkins University, and University of California, San Francisco. Peer review workflows emphasize external referees drawn from networks spanning the American Association for the Advancement of Science membership and societies such as the Society for Neuroscience. Policies on reproducibility, data availability, and conflict of interest align with standards advocated by funders including the Wellcome Trust and regulatory frameworks upheld by agencies like the Food and Drug Administration. Editorial decisions have at times reflected tensions between academic editors affiliated with places like Massachusetts General Hospital and corporate publishing strategies.

Open Access and Licensing

The publisher offers hybrid and fully open-access options, implementing article processing charges that mirror industry practices observed across publishers including Springer Nature and Wiley-Blackwell. Licensing choices commonly employ Creative Commons frameworks used by organizations such as Creative Commons and comply with mandates from funders like the National Institutes of Health and the European Commission. Initiatives to increase open-data and preprint integration have intersected with platforms such as bioRxiv and arXiv (arXiv) and with open-science campaigns led by groups like SPARC (the Scholarly Publishing and Academic Resources Coalition).

Notable Editors and Contributors

Editorial leadership and contributing authors have included prominent scientists, clinicians, and policy figures drawn from institutions such as Harvard University, Yale University, Princeton University, Columbia University, University of Chicago, Imperial College London, the Scripps Research Institute, and the Max Planck Society. Guest editors and commentary authors have comprised Nobel laureates affiliated with bodies like the Nobel Prize in Physiology or Medicine laureates and influential figures associated with the Royal Society and the National Academy of Sciences.

Criticism and Controversies

The publisher has faced criticism familiar to major commercial publishers: disputes over subscription pricing with consortia including Projekt DEAL and research libraries at institutions such as University of California, Berkeley, debates over article processing charges raised by funders like the Wellcome Trust, and controversies surrounding editorial independence highlighted in high-profile retractions and expressions of concern involving work from laboratories at places such as University of Oxford and Stanford University. Advocacy groups such as Open Science proponents and organizations including Science for the People have contested aspects of corporate publishing practices, while policy debates have involved lawmakers and agencies across regions including European Union research policy forums.

Category:Academic publishing companies Category:Science publishing